Elevance Health ELV Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 356.1%+0.6pp | 355.5%+0.5pp | 355%-0.5pp | 355.5%-0.8pp | 356.2%-1.1pp | |
| Net margin | 11.1%-0.6pp | 11.7%-0.5pp | 12.3%-0.8pp | 13.1%-1.1pp | 14.2%-0.4pp | |
| Returns | ||||||
| Return on equity | 50.5%-2.1pp | 52.6%-1.5pp | 54.2%-3.0pp | 57.2%-4.2pp | 61.3%-1.8pp | |
| Efficiency | ||||||
| Asset turnover | 6.5×0.0× | 6.5×+0.1× | 6.4×+0.1× | 6.3×+0.1× | 6.2×0.0× | |
| Liquidity | ||||||
| Current ratio | 6×0.0× | 6×+0.1× | 5.9×+0.1× | 5.8×0.0× | 5.9×+0.1× | |
| Leverage | ||||||
| Debt-to-equity | 2.8×+0.1× | 2.8×0.0× | 2.8×+0.1× | 2.6×+0.1× | 2.6×+0.1× | |
| Valuation | ||||||
| Market capitalization | $300.02B-10.2% | $334.18B-2.2% | $341.83B-12.3% | $389.82B-9.5% | $430.59B-4.9% | |
| Price / earnings | 55×-4.4× | 59.4×-0.5× | 60×-5.7× | 65.6×-2.9× | 68.6×-2.7× | |
| Price / sales | 1.5×-0.2× | 1.8×-0.1× | 1.8×-0.3× | 2.2×-0.3× | 2.4×-0.2× | |
| Price / book | 6.8×-0.9× | 7.7×-0.3× | 8×-1.1× | 9.1×-1.0× | 10.1×-0.7× | |
| Dividend yield | 8.2%+0.8pp | 7.4%+0.2pp | 7.2%+0.9pp | 6.4%+0.6pp | 5.7%+0.4pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Elevance Health's ratios come from?
- Every ratio is computed from Elevance Health's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
